Article
Structure- and sequence-based design of synthetic single-domain antibody libraries
1 Jan 2020
Abstract excerpt
Single-domain antibody fragments known as VHH have emerged in the pharmaceutical industry as useful biotherapeutics. These molecules, which are naturally produced by camelids, share the characteristics of high affinity and specificity with traditional human immunoglobulins, while consisting of only a single heavy chain. Currently, the most common method for generating VHH is via animal immunization, which can be...
Topics
Join the communities discussing this publication.
